RNA Analysis Transcriptomics Market Insights, Global Outlook and Forecast 2022-2028
RNA Analysis Transcriptomics Market Insights, Global Outlook and Forecast 2022-2028
Discover the latest insights into the booming RNA Analysis Transcriptomics Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
The latest research study released by Market IntelliX evaluates market size and forecasts of RNA Analysis Transcriptomics in Global, including the following market information:
Global RNA Analysis Transcriptomics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global RNA Analysis Transcriptomics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Microarrays Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNA Analysis Transcriptomics include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, Illumina, QIAGEN N.V., F. Hoffmann-La Roche, Danaher Corporation and Fluidigm Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the RNA Analysis Transcriptomics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global RNA Analysis Transcriptomics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global RNA Analysis Transcriptomics Market Segment Percentages, by Type, 2021 (%)
Microarrays
Sequencing
Polymerase Chain Reaction (PCR)
RNA Interference
Global RNA Analysis Transcriptomics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global RNA Analysis Transcriptomics Market Segment Percentages, by Application, 2021 (%)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals
Global RNA Analysis Transcriptomics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global RNA Analysis Transcriptomics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA Analysis Transcriptomics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies RNA Analysis Transcriptomics revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market Some of the prominent key players covered:
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Agilent Technologies
Illumina
QIAGEN N.V.
F. Hoffmann-La Roche
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech
Acobiom
GenXPro
CD Genomics
Promega Corporation
Lexogen
Cenix BioScience
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 RNA Analysis Transcriptomics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA Analysis Transcriptomics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Analysis Transcriptomics Overall Market Size
2.1 Global RNA Analysis Transcriptomics Market Size: 2021 VS 2028
2.2 Global RNA Analysis Transcriptomics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA Analysis Transcriptomics Players in Global Market
3.2 Top Global RNA Analysis Transcriptomics Companies Ranked by Revenue
3.3 Global RNA Analysis Transcriptomics Revenue by Companies
3.4 Top 3 and Top 5 RNA Analysis Transcriptomics Companies in Global Market, by Revenue in 2021
3.5 Global Companies RNA Analysis Transcriptomics Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA Analysis Transcriptomics Players in Global Market
3.6.1 List of Global Tier 1 RNA Analysis Transcriptomics Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA Analysis Transcriptomics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global RNA Analysis Transcriptomics Market Size Markets, 2021 & 2028
4.1.2 Microarrays
4.1.3 Sequencing
4.1.4 Polymerase Chain Reaction (PCR)
4.1.5 RNA Interference
4.2 By Type - Global RNA Analysis Transcriptomics Revenue & Forecasts
4.2.1 By Type - Global RNA Analysis Transcriptomics Revenue, 2017-2022
4.2.2 By Type - Global RNA Analysis Transcriptomics Revenue, 2023-2028
4.2.3 By Type - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA Analysis Transcriptomics Market Size, 2021 & 2028
5.1.2 Academic & Research Institutes
5.1.3 Pharmaceutical & Biotechnology Companies
5.1.4 Hospitals
5.2 By Application - Global RNA Analysis Transcriptomics Revenue & Forecasts
5.2.1 By Application - Global RNA Analysis Transcriptomics Revenue, 2017-2022
5.2.2 By Application - Global RNA Analysis Transcriptomics Revenue, 2023-2028
5.2.3 By Application - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global RNA Analysis Transcriptomics Market Size, 2021 & 2028
6.2 By Region - Global RNA Analysis Transcriptomics Revenue & Forecasts
6.2.1 By Region - Global RNA Analysis Transcriptomics Revenue, 2017-2022
6.2.2 By Region - Global RNA Analysis Transcriptomics Revenue, 2023-2028
6.2.3 By Region - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America RNA Analysis Transcriptomics Revenue, 2017-2028
6.3.2 US RNA Analysis Transcriptomics Market Size, 2017-2028
6.3.3 Canada RNA Analysis Transcriptomics Market Size, 2017-2028
6.3.4 Mexico RNA Analysis Transcriptomics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe RNA Analysis Transcriptomics Revenue, 2017-2028
6.4.2 Germany RNA Analysis Transcriptomics Market Size, 2017-2028
6.4.3 France RNA Analysis Transcriptomics Market Size, 2017-2028
6.4.4 U.K. RNA Analysis Transcriptomics Market Size, 2017-2028
6.4.5 Italy RNA Analysis Transcriptomics Market Size, 2017-2028
6.4.6 Russia RNA Analysis Transcriptomics Market Size, 2017-2028
6.4.7 Nordic Countries RNA Analysis Transcriptomics Market Size, 2017-2028
6.4.8 Benelux RNA Analysis Transcriptomics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia RNA Analysis Transcriptomics Revenue, 2017-2028
6.5.2 China RNA Analysis Transcriptomics Market Size, 2017-2028
6.5.3 Japan RNA Analysis Transcriptomics Market Size, 2017-2028
6.5.4 South Korea RNA Analysis Transcriptomics Market Size, 2017-2028
6.5.5 Southeast Asia RNA Analysis Transcriptomics Market Size, 2017-2028
6.5.6 India RNA Analysis Transcriptomics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America RNA Analysis Transcriptomics Revenue, 2017-2028
6.6.2 Brazil RNA Analysis Transcriptomics Market Size, 2017-2028
6.6.3 Argentina RNA Analysis Transcriptomics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue, 2017-2028
6.7.2 Turkey RNA Analysis Transcriptomics Market Size, 2017-2028
6.7.3 Israel RNA Analysis Transcriptomics Market Size, 2017-2028
6.7.4 Saudi Arabia RNA Analysis Transcriptomics Market Size, 2017-2028
6.7.5 UAE RNA Analysis Transcriptomics Market Size, 2017-2028
7 Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Major Product Offerings
7.1.4 Thermo Fisher Scientific RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Corporate Summary
7.2.2 Bio-Rad Laboratories Business Overview
7.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Major Product Offerings
7.2.4 Bio-Rad Laboratories RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.2.5 Bio-Rad Laboratories Key News
7.3 Merck KGaA
7.3.1 Merck KGaA Corporate Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA RNA Analysis Transcriptomics Major Product Offerings
7.3.4 Merck KGaA RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.3.5 Merck KGaA Key News
7.4 Agilent Technologies
7.4.1 Agilent Technologies Corporate Summary
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies RNA Analysis Transcriptomics Major Product Offerings
7.4.4 Agilent Technologies RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.4.5 Agilent Technologies Key News
7.5 Illumina
7.5.1 Illumina Corporate Summary
7.5.2 Illumina Business Overview
7.5.3 Illumina RNA Analysis Transcriptomics Major Product Offerings
7.5.4 Illumina RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.5.5 Illumina Key News
7.6 QIAGEN N.V.
7.6.1 QIAGEN N.V. Corporate Summary
7.6.2 QIAGEN N.V. Business Overview
7.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Major Product Offerings
7.6.4 QIAGEN N.V. RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.6.5 QIAGEN N.V. Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Major Product Offerings
7.7.4 F. Hoffmann-La Roche RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Danaher Corporation
7.8.1 Danaher Corporation Corporate Summary
7.8.2 Danaher Corporation Business Overview
7.8.3 Danaher Corporation RNA Analysis Transcriptomics Major Product Offerings
7.8.4 Danaher Corporation RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.8.5 Danaher Corporation Key News
7.9 Fluidigm Corporation
7.9.1 Fluidigm Corporation Corporate Summary
7.9.2 Fluidigm Corporation Business Overview
7.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Major Product Offerings
7.9.4 Fluidigm Corporation RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.9.5 Fluidigm Corporation Key News
7.10 Eurofins Scientific
7.10.1 Eurofins Scientific Corporate Summary
7.10.2 Eurofins Scientific Business Overview
7.10.3 Eurofins Scientific RNA Analysis Transcriptomics Major Product Offerings
7.10.4 Eurofins Scientific RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.10.5 Eurofins Scientific Key News
7.11 Sequentia Biotech
7.11.1 Sequentia Biotech Corporate Summary
7.11.2 Sequentia Biotech Business Overview
7.11.3 Sequentia Biotech RNA Analysis Transcriptomics Major Product Offerings
7.11.4 Sequentia Biotech RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.11.5 Sequentia Biotech Key News
7.12 Acobiom
7.12.1 Acobiom Corporate Summary
7.12.2 Acobiom Business Overview
7.12.3 Acobiom RNA Analysis Transcriptomics Major Product Offerings
7.12.4 Acobiom RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.12.5 Acobiom Key News
7.13 GenXPro
7.13.1 GenXPro Corporate Summary
7.13.2 GenXPro Business Overview
7.13.3 GenXPro RNA Analysis Transcriptomics Major Product Offerings
7.13.4 GenXPro RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.13.5 GenXPro Key News
7.14 CD Genomics
7.14.1 CD Genomics Corporate Summary
7.14.2 CD Genomics Business Overview
7.14.3 CD Genomics RNA Analysis Transcriptomics Major Product Offerings
7.14.4 CD Genomics RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.14.5 CD Genomics Key News
7.15 Promega Corporation
7.15.1 Promega Corporation Corporate Summary
7.15.2 Promega Corporation Business Overview
7.15.3 Promega Corporation RNA Analysis Transcriptomics Major Product Offerings
7.15.4 Promega Corporation RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.15.5 Promega Corporation Key News
7.16 Lexogen
7.16.1 Lexogen Corporate Summary
7.16.2 Lexogen Business Overview
7.16.3 Lexogen RNA Analysis Transcriptomics Major Product Offerings
7.16.4 Lexogen RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.16.5 Lexogen Key News
7.17 Cenix BioScience
7.17.1 Cenix BioScience Corporate Summary
7.17.2 Cenix BioScience Business Overview
7.17.3 Cenix BioScience RNA Analysis Transcriptomics Major Product Offerings
7.17.4 Cenix BioScience RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)
7.17.5 Cenix BioScience Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. RNA Analysis Transcriptomics Market Opportunities & Trends in Global Market
Table 2. RNA Analysis Transcriptomics Market Drivers in Global Market
Table 3. RNA Analysis Transcriptomics Market Restraints in Global Market
Table 4. Key Players of RNA Analysis Transcriptomics in Global Market
Table 5. Top RNA Analysis Transcriptomics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global RNA Analysis Transcriptomics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global RNA Analysis Transcriptomics Revenue Share by Companies, 2017-2022
Table 8. Global Companies RNA Analysis Transcriptomics Product Type
Table 9. List of Global Tier 1 RNA Analysis Transcriptomics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA Analysis Transcriptomics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global RNA Analysis Transcriptomics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global RNA Analysis Transcriptomics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global RNA Analysis Transcriptomics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global RNA Analysis Transcriptomics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global RNA Analysis Transcriptomics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific RNA Analysis Transcriptomics Product Offerings
Table 32. Thermo Fisher Scientific RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 33. Bio-Rad Laboratories Corporate Summary
Table 34. Bio-Rad Laboratories RNA Analysis Transcriptomics Product Offerings
Table 35. Bio-Rad Laboratories RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 36. Merck KGaA Corporate Summary
Table 37. Merck KGaA RNA Analysis Transcriptomics Product Offerings
Table 38. Merck KGaA RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies RNA Analysis Transcriptomics Product Offerings
Table 41. Agilent Technologies RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 42. Illumina Corporate Summary
Table 43. Illumina RNA Analysis Transcriptomics Product Offerings
Table 44. Illumina RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 45. QIAGEN N.V. Corporate Summary
Table 46. QIAGEN N.V. RNA Analysis Transcriptomics Product Offerings
Table 47. QIAGEN N.V. RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Corporate Summary
Table 49. F. Hoffmann-La Roche RNA Analysis Transcriptomics Product Offerings
Table 50. F. Hoffmann-La Roche RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 51. Danaher Corporation Corporate Summary
Table 52. Danaher Corporation RNA Analysis Transcriptomics Product Offerings
Table 53. Danaher Corporation RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 54. Fluidigm Corporation Corporate Summary
Table 55. Fluidigm Corporation RNA Analysis Transcriptomics Product Offerings
Table 56. Fluidigm Corporation RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 57. Eurofins Scientific Corporate Summary
Table 58. Eurofins Scientific RNA Analysis Transcriptomics Product Offerings
Table 59. Eurofins Scientific RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 60. Sequentia Biotech Corporate Summary
Table 61. Sequentia Biotech RNA Analysis Transcriptomics Product Offerings
Table 62. Sequentia Biotech RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 63. Acobiom Corporate Summary
Table 64. Acobiom RNA Analysis Transcriptomics Product Offerings
Table 65. Acobiom RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 66. GenXPro Corporate Summary
Table 67. GenXPro RNA Analysis Transcriptomics Product Offerings
Table 68. GenXPro RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 69. CD Genomics Corporate Summary
Table 70. CD Genomics RNA Analysis Transcriptomics Product Offerings
Table 71. CD Genomics RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 72. Promega Corporation Corporate Summary
Table 73. Promega Corporation RNA Analysis Transcriptomics Product Offerings
Table 74. Promega Corporation RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 75. Lexogen Corporate Summary
Table 76. Lexogen RNA Analysis Transcriptomics Product Offerings
Table 77. Lexogen RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 78. Cenix BioScience Corporate Summary
Table 79. Cenix BioScience RNA Analysis Transcriptomics Product Offerings
Table 80. Cenix BioScience RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. RNA Analysis Transcriptomics Segment by Type in 2021
Figure 2. RNA Analysis Transcriptomics Segment by Application in 2021
Figure 3. Global RNA Analysis Transcriptomics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global RNA Analysis Transcriptomics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global RNA Analysis Transcriptomics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA Analysis Transcriptomics Revenue in 2021
Figure 8. By Type - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 9. By Application - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 10. By Region - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 11. By Country - North America RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 12. US RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 16. Germany RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 17. France RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 24. China RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 28. India RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 30. Brazil RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue Market Share, 2017-2028
Figure 33. Turkey RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bio-Rad Laboratories RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck KGaA RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Agilent Technologies RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Illumina RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. QIAGEN N.V. RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Danaher Corporation RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Fluidigm Corporation RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eurofins Scientific RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sequentia Biotech RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Acobiom RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GenXPro RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. CD Genomics RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Promega Corporation RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Lexogen RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Cenix BioScience RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Research Methodology:
RNA Analysis Transcriptomics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|